Yes, a Patient with a Blood Glucose of 82 mg/dL Can Have Diabetic Ketoacidosis
A patient with a blood glucose level of 82 mg/dL can absolutely have diabetic ketoacidosis (DKA), specifically a variant called euglycemic DKA, especially if they are taking SGLT2 inhibitors or have other risk factors.1, 2
Understanding Euglycemic DKA
Euglycemic DKA is characterized by:
- Metabolic acidosis
- Presence of ketones in blood and urine
- High anion gap
- Blood glucose levels <200 mg/dL (sometimes as low as 75-90 mg/dL)2, 3
Key Risk Factors for Euglycemic DKA
- SGLT2 inhibitor use - These medications increase the risk of DKA in both type 1 and type 2 diabetes by promoting glycosuria while maintaining ketogenesis4, 1
- Prolonged fasting or starvation
- Low carbohydrate diets (<20-30g daily)
- Pregnancy
- Alcohol consumption
- Missed insulin doses
- Illness or infection1
Diagnostic Approach
When evaluating a patient with normal blood glucose but suspected DKA:
- Measure blood β-hydroxybutyrate (bOHB) - This is the preferred method for diagnosis rather than urine ketones4, 1
- Check venous blood gases - Look for pH <7.3 and bicarbonate <18 mEq/L
- Calculate anion gap - An elevated anion gap (>12 mEq/L) supports the diagnosis
- Evaluate electrolytes - Particularly sodium, potassium, and chloride levels
- Consider other causes of ketosis with normal glucose:
Important Clinical Considerations
- Urine ketone tests are inadequate for diagnosis and monitoring of DKA as they primarily detect acetoacetate and acetone, not β-hydroxybutyrate (the predominant ketone in DKA)4
- SGLT2 inhibitors create a unique risk for euglycemic DKA as they promote urinary glucose excretion while maintaining ketogenesis, resulting in ketoacidosis without marked hyperglycemia1, 5
- Case reports document very low glucose levels in euglycemic DKA, with documented cases showing glucose as low as 75 mg/dL2
Management of Euglycemic DKA
The treatment principles are similar to classic DKA but with important differences:
- Administer glucose-containing IV fluids immediately - Unlike classic DKA, dextrose should be given early to induce endogenous insulin secretion and halt ketogenesis5, 3
- Provide insulin therapy - Continuous insulin infusion at 0.1 unit/kg/hr is recommended1
- Correct fluid and electrolyte imbalances
- Monitor ketones using blood bOHB measurements rather than urine ketones4, 1
- Continue treatment until DKA resolves - Resolution criteria include glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap <12 mEq/L1
Common Pitfalls to Avoid
- Failing to check for ketones when glucose is normal - This is a critical mistake that can delay diagnosis of euglycemic DKA1
- Relying solely on urine ketones - Blood bOHB measurement is more accurate and preferred4, 1
- Stopping insulin too early - Treatment should continue until ketoacidosis resolves, not just until glucose normalizes1
- Missing the diagnosis due to normal glucose levels - Always consider euglycemic DKA in patients with risk factors (especially SGLT2 inhibitor use) who present with symptoms of DKA despite normal glucose3
In conclusion, the presence of a normal blood glucose level (82 mg/dL) does not exclude the diagnosis of DKA, particularly in patients with risk factors for euglycemic DKA. Proper diagnosis requires assessment of blood ketones, acid-base status, and anion gap, regardless of the blood glucose level.